Client News

InflaRx Reports Second Quarter 2024 Financial Results and Provides Business Update

Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers

Formycon invites to conference call on 2024 half-year results and announces participation in international investor conferences

Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results

leon-nanodrugs secures funds in a series D financing to broaden portfolio in first single-use high throughput production systems for nanoencapsulation

QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform

Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone

CARBIOS and FCC Environment announce joint project to establish UK-based PET biorecycling facility using CARBIOS’ licensed technology

CARBIOS and SASA enter discussions for license of 100k ton/year PET biorecycling facility in Turkey

InflaRx to Report Second Quarter 2024 Results on August 8, 2024